TwinStrand Biosciences CEO and leadership

Jesse Salk currently works as the CEO and co-founder of TwinStrand Biosciences. He previously worked at the University of Washington as a senior fellow in the division of oncology.

Elena Cant leads TwinStrand’s operational organization. She has more than 20 years of diverse business experience, the last 15 of which has focused on life sciences. Elena worked as a consultant at McKinsey & Company serving major pharmaceutical and device companies in the US and Europe, followed by global strategic and operational leadership roles at Mead Johnson Nutrition, Hospira, and Takeda Pharmaceuticals. Elena received her MBA from the University of Chicago.

Jeff Grainger is an attorney, specializing in intellectual property, with more than 25 years’ of experience in early stage technology companies. In addition to his role at TwinStrand, Jeff serves as Chairman of the Board at Signum Surgical and is an advisor to several other early stage medtech companies in the US and abroad. Jeff served as a Managing Partner at The Foundry, a medical device incubator where he played a major role in launching FIRE1, Nuvaira, Twelve, Cotera, eValve, and other successful ventures. Jeff’s earlier positions include Vice President of Corporate Affairs and General Counsel at Xtent and Chief Patent Counsel at Heartport. He previously founded patent automation start-up First to File, served as an attorney at Townsend & Townsend, and was a robotics engineer at Boeing. Jeff holds a JD from the University of Washington and a BS in Mechanical Engineering from Stanford.

Jesse Salk currently works as the CEO and co-founder of TwinStrand Biosciences. He previously worked at the University of Washington as a senior fellow in the division of oncology.

Jesse Salk currently works as the CEO and co-founder of TwinStrand Biosciences. He previously worked at the University of Washington as a senior fellow in the division of oncology.